SecBot SecBot
6-K ·Filed Jul 23, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001575872-26-000531
Actionable Insight • Neutral

These filings are routine governance updates with no trading implications. Monitor the next quarterly earnings release for financial performance and any strategic updates from the new independent director, Mr. Srikanth Velamakanni, whose AI expertise could signal a future strategic focus.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$11.80
T+0 close · Jul 23, 2026 · via day close
Latest settled
+9.32%
T+60 · $12.90
Vs SPY
+4.77%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 23 $11.80entry
  2. T+1 · 4mo ago −0.08%α −0.19% · $11.79
  3. T+5 · 4mo ago +0.25%α −0.22% · $11.83
  4. T+20 · 3mo ago +2.63%α −0.68% · $12.11
  5. T+60 · 5w ago +9.32%α +4.77% · $12.90
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's filed two 6-Ks on July 23, 2026, reporting the outcome of its 42nd Annual General Meeting. Shareholders approved all resolutions, including the re-appointment of Dr. K P Krishnan as an Independent Director, the appointment of Mr. Srikanth Velamakanni as a new Independent Director, and the appointment of M/s Deloitte Haskins & Sells, LLP as the new statutory auditors. These are routine governance items with no material financial impact, confirming the company's stable corporate governance structure.

Key Facts

  • Shareholders approved all 7 resolutions at the 42nd AGM held on July 23, 2026.
  • Dr. K P Krishnan was re-appointed as an Independent Director for a second term from Jan 7, 2027 to Jan 6, 2032.
  • Mr. Srikanth Velamakanni (Co-Founder & Group CEO of Fractal) was appointed as an Independent Director from July 1, 2026 to June 30, 2031.
  • M/s Deloitte Haskins & Sells, LLP was appointed as Statutory Auditors for a five-year term from the 42nd AGM to the 47th AGM.
  • A final dividend of Rs. 8 per equity share for FY2025-26 was declared.
  • The AGM was held via video conferencing with 86 members holding 22,25,59,764 shares in attendance.

Financial Impact

No financial impact. Routine governance approvals with no new financial disclosures.

Risk Factors

  • No material risks identified from these filings.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (RDY), Batch item 10001575872-26-000531
Document: 0001575872-26-000531-index.html0001575872-26-000530
Document: 0001575872-26-000531.txt0001575872-26-000531
6-K Filing (RDY), Batch item 40001575872-26-000530
Document: 0001575872-26-000530-index.html0001575872-26-000531
Document: 0001575872-26-000530.txt0001575872-26-000531
6-K Filing (RDY), Batch item 70001575872-26-000531

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 23, 2026